• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number 10606
Device Problems Obstruction of Flow (2423); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiopulmonary Arrest (1765); Death (1802); Thrombosis (2100)
Event Date 04/29/2019
Event Type  Death  
Manufacturer Narrative
Device is a combination product.
 
Event Description
(b)(6) clinical study.It was reported that the patient died.In (b)(6) 2018, the patient was referred for elective cardiac catheterization and the index procedure was performed on the same day.The target lesion # 1 was located in the proximal left circumflex (lcx) artery with 80% stenosis and was 24 mm long with a reference vessel diameter of 3.00 mm.The target lesion was treated with direct placement of a 3.00 x 38 mm study stent.Following post dilatation, residual stenosis was 0% with timi 3 flow.The target lesion # 2 was a long lesion extending from proximal right coronary artery (rca) to mid rca with 80% stenosis and was 56 mm long with a reference vessel diameter of 2.75 mm.The target lesion was treated with direct placement of 2.75 x 38 mm and 2.75 x 32 mm study stents.Following post dilatation, residua stenosis was 0% with timi 3 flow.Post procedure, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2019, the patient was brought to the emergency room via emergency medical services.The patient was found to be unresponsive, pulseless and apneic.The patient was also noted to have shortness of breath.On arrival to emergency department, electrocardiogram (ekg) revealed asystole cardiac rhythm and lab investigation revealed elevated troponin with the value 0.846 ng/ml (uln: 0.056 ng/ml).Physical examination revealed patient was cool to touch but not cold, no evidence of lividity and rigor mortis were noted, and pupils were dilated and fixed.Subsequently, endotracheal tube was placed for the management of the symptoms.On further examination, blood pressure was 153/66, heart rate was 81 and ventricular tachycardia was noted.The precordial thump was started in response to pulseless ventricular tachycardia and subject gave response but lost the pulse again.Amiodarone was initiated, cardiopulmonary resuscitation (cpr) was given and spontaneous circulation (rosc) was detected, however reports could not be obtained.On the same day, the patient died due to cardiopulmonary arrest.A death certificate is not available and an autopsy was not performed.
 
Manufacturer Narrative
Device is a combination product.
 
Event Description
Evolve short dapt clinical study.It was reported that the patient died.In (b)(6) 2018, the patient was referred for elective cardiac catheterization and the index procedure was performed on the same day.The target lesion #1 was located in the proximal left circumflex (lcx) artery with 80% stenosis and was 24mm long with a reference vessel diameter of 3.00 mm.The target lesion was treated with direct placement of a 3.00x38mm study stent.Following post dilatation, residual stenosis was 0% with timi 3 flow.The target lesion #2 was a long lesion extending from proximal right coronary artery (rca) to mid rca with 80% stenosis and was 56mm long with a reference vessel diameter of 2.75mm.The target lesion was treated with direct placement of 2.75x38mm and 2.75x32mm study stents.Following post dilatation, residua stenosis was 0% with timi 3 flow.Post procedure, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2019, the patient was brought to the emergency room via emergency medical services.The patient was found to be unresponsive, pulseless and apneic.The patient was also noted to have shortness of breath.On arrival to emergency department, electrocardiogram (ekg) revealed asystole cardiac rhythm and lab investigation revealed elevated troponin with the value 0.846 ng/ml (uln: 0.056 ng/ml).Physical examination revealed patient was cool to touch but not cold, no evidence of lividity and rigor mortis were noted, and pupils were dilated and fixed.Subsequently, endotracheal tube was placed for the management of the symptoms.On further examination, blood pressure was 153/66, heart rate was 81 and ventricular tachycardia was noted.The precordial thump was started in response to pulseless ventricular tachycardia and subject gave response but lost the pulse again.Amiodorone was initiated, cardiopulmonary resuscitation (cpr) was given and spontaneous circulation (rosc) was detected, however reports could not be obtained.On the same day, the patient died due to cardiopulmonary arrest.A death certificate is not available and an autopsy was not performed.It was further reported that at the time of event, the patient was on aspirin and clopidogrel.
 
Manufacturer Narrative
Device is a combination product.
 
Event Description
Evolve short dapt clinical study it was reported that the patient died.In (b)(6) 2018, the patient was referred for elective cardiac catheterization and the index procedure was performed on the same day.The target lesion #1 was located in the proximal left circumflex (lcx) artery with 80% stenosis and was 24mm long with a reference vessel diameter of 3.00 mm.The target lesion was treated with direct placement of a 3.00x38mm study stent.Following post dilatation, residual stenosis was 0% with timi 3 flow.The target lesion #2 was a long lesion extending from proximal right coronary artery (rca) to mid rca with 80% stenosis and was 56mm long with a reference vessel diameter of 2.75mm.The target lesion was treated with direct placement of 2.75x38mm and 2.75x32mm study stents.Following post dilatation, residual stenosis was 0% with timi 3 flow.Post procedure, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2019, the patient was brought to the emergency room via emergency medical services.The patient was found to be unresponsive, pulseless and apneic.The patient was also noted to have shortness of breath.On arrival to emergency department, electrocardiogram (ekg) revealed asystole cardiac rhythm and lab investigation revealed elevated troponin with the value 0.846 ng/ml (uln: 0.056 ng/ml).Physical examination revealed patient was cool to touch but not cold, no evidence of lividity and rigor mortis were noted, and pupils were dilated and fixed.Subsequently, endotracheal tube was placed for the management of the symptoms.On further examination, blood pressure was 153/66, heart rate was 81 and ventricular tachycardia was noted.The precordial thump was started in response to pulseless ventricular tachycardia and subject gave response but lost the pulse again.Amiodarone was initiated, cardiopulmonary resuscitation (cpr) was given and spontaneous circulation (rosc) was detected, however reports could not be obtained.On the same day, the patient died due to cardiopulmonary arrest.A death certificate is not available and an autopsy was not performed.It was further reported that at the time of event, the patient was on aspirin and clopidogrel.It was also reported that stent thrombosis occurred per adjudication.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key8668990
MDR Text Key147032331
Report Number2134265-2019-05842
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08714729840343
UDI-Public08714729840343
Combination Product (y/n)N
PMA/PMN Number
P150003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 08/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/04/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/04/2018
Device Model Number10606
Device Catalogue Number10606
Device Lot Number0021118813
Was Device Available for Evaluation? No
Date Manufacturer Received07/26/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age62 YR
-
-